Relationship between serum resistin concentrations with metabolic syndrome and its components in an Iranian population

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 9, Issue 4, 2015, Pages 266-270

  Asgary, Sedigheh ^a   Samsamshariat, Seyyed Ziaedin ^b   Ghorbani, Ahmad ^b   Keshvari, Mahtab ^a   Sahebkar, Amirhossein ^c   Sarrafzadegan, Nizal ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipokine; Cardiovascular disease; Metabolic syndrome; Resistin

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID; RETN PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION PROCESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC SYNDROME X; POPULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX ALLOCATION; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; FOLLOW UP; IRAN; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTOR;

ADULT; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROGNOSIS; RESISTIN; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84955186183     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.09.007     Document Type: Article

References (41)

1. K. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, and et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 16 2009 1640 1645 10.1161/CIRCULATIONAHA.109.192644
2. S.M. Grundy, H.B. Brewer, J.I. Cleeman, S.C. Smith, and C. Lenfant Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition Circulation 109 3 2004 433 438 10.1161/01.CIR.0000111245.75752.C6
3. C. Espinola-Klein, T. Gori, S. Blankenberg, and T. Munzel Inflammatory markers and cardiovascular risk in the metabolic syndrome Front Biosci 16 2010 1663 1674 10.2741/3812
4. A. Nikolopoulou, and N.P. Kadoglou Obesity and metabolic syndrome as related to cardiovascular disease Expert Rev Cardiovasc Ther 10 7 2012 933 939 10.1586/erc.12.74
5. A. Shah, N. Mehta, and M.P. Reilly Adipose inflammation, insulin resistance, and cardiovascular disease J Parenter Enteral Nutr 32 6 2008 44 638 10.1177/0148607108325251
6. C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.R. Banerjee, C.M. Wright, and et al. The hormone resistin links obesity to diabetes Nature 409 6818 2001 307 312 10.1038/35053000
7. S.L. Lay, J. Boucher, A. Rey, I. Castan-Laurell, S. Krief, P. Ferré, and et al. Decreased resistin expression in mice with different sensitivities to a high-fat diet Biochem Biophys Res Commun 289 2 2001 564 567 10.1006/bbrc.2001.6015
8. J.M. Way, C.Z. Görgün, Q. Tong, K.T. Uysal, K.K. Brown, W.W. Harrington, and et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists J Biol Chem 276 28 2001 25651 25653 10.1074/jbc.C100189200
9. M.P. Reilly, M. Lehrke, M.L. Wolfe, A. Rohatgi, M.A. Lazar, and D.J. Rader Resistin is an inflammatory marker of atherosclerosis in humans Circulation 111 7 2005 932 939 10.1161/01.CIR.0000155620.10387.43
10. J. Axelsson, A. Bergsten, A. Qureshi, O. Heimbürger, P. Barany, F. Lönnqvist, and et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance Kidney Int 69 3 2006 596 604 10.1038/sj.ki.5000089
11. S. Bo, R. Gambino, A. Pagani, S. Guidi, L. Gentile, M. Cassader, and et al. Relationships between human serum resistin, inflammatory markers and insulin resistance Int J Obes 29 11 2005 1315 1320 10.1038/sj.ijo.0803037
12. N. Al-Daghri, R. Chetty, P.G. McTernan, K. Al-Rubean, O. Al-Attas, A. Jones, and et al. Serum resistin is associated with C-reactive protein and LDL-cholesterol in type 2 diabetes and coronary artery disease in a Saudi population Cardiovasc Diabetol 4 1 2005 10 10.1186/1475-2840-4-10
13. C.L. Aquilante, L.A. Kosmiski, S.D. Knutsen, and I. Zineh Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults Metabolism 57 2008 494 501 10.1016/j.metabol.2007.11.010
14. C. Pagano, O. Marin, A. Calcagno, P. Schiappelli, C. Pilon, G. Milan, and et al. Increased serum resistin in adults with Prader-Willi syndrome is related to obesity and not to insulin resistance J Clin Endocrinol Metab 90 7 2005 4335 4340 10.1210/jc.2005-0293
15. M. Matsuda, F. Kawasaki, K. Yamada, Y. Kanda, M. Saito, M. Eto, and et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects Diabet Med 21 8 2004 881 888 10.1111/j.1464-5491.2004.01261.x
16. M.S. Burnett, J.M. Devaney, R.J. Adenika, R. Lindsay, and B.V. Howard Cross-sectional associations of resistin, coronary heart disease, and insulin resistance J Clin Endocrinol Metab 91 1 2006 64 68 10.1210/jc.2005-1653
17. M. Farvid, T. Ng, D. Chan, P. Barrett, and G. Watts Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia Diabetes Obes Metab 7 4 2005 406 413 10.1111/j.1463-1326.2004.00410.x
18. K. Utzschneider, D. Carr, J. Tong, T. Wallace, R. Hull, S. Zraika, and et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans Diabetologia 48 11 2005 2330 2333 10.1007/s00125-005-1932-y
19. C.C. Zou, L. Liang, F. Hong, J.F. Fu, and Z.Y. Zhao Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children Endocr J 52 5 2005 519 524 10.1507/endocrj.52.519
20. D.R. Schwartz, and M.A. Lazar Human resistin: found in translation from mouse to man Trends Endocrinol Metab 22 7 2011 259 265 10.1016/j.tem.2011.03.005
21. N. Sarraf-Zadegan, G. Sadri, H. Malekafzali, M. Baghaei, N. Mohammadi Fard, S. Shahrokhi, and et al. Isfahan Healthy Heart Program: a comprehensive integrated community-based program for cardiovascular disease prevention and control Acta Cardiol 58 4 2003 309 320
22. N. Sarrafzadegan, A. Baghaei, G. Sadri, R. Kelishadi, H. Malekafzali, M. Boshtam, and et al. Isfahan Healthy Heart Program: evaluation of comprehensive, community-based interventions for non-communicable disease prevention Prev Control 2 2 2006 73 84 10.1016/j.precon.2006.10.003
23. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 6 1972 499 502
24. S.M. Grundy, D. Bilheimer, A. Chait, L.T. Clark, DenkeM, R.J. Havel, and et al. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II) JAMA 269 23 1993 3015 3023 10.1001/jama.1993.03500230097036
25. T. Yokota, K. Oritani, I. Takahashi, J. Ishikawa, A. Matsuyama, N. Ouchi, and et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 5 2000 1723 1732
26. N. Ouchi, S. Kihara, Y. Arita, M. Nishida, A. Matsuyama, Y. Okamoto, and et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 8 2001 1057 1063 10.1161/01.CIR.103.8.1057
27. M. Matsubara, S. Maruoka, and S. Katayose Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women Eur J Endocrinol 1 147 2002 173 180 10.1530/eje.0.1470173
28. N. Kubota, Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, and et al. Disruption of adiponectin causes insulin resistance and neointimal formation J Biol Chem 277 29 2002 25863 25866 10.1074/jbc.C200251200
29. K. Azuma, F. Katsukawa, S. Oguchi, M. Murata, H. Yamazaki, A. Shimada, and et al. Correlation between serum resistin level and adiposity in obese individuals Obes Res 11 8 2003 997 1001 10.1038/oby.2003.137
30. J.V. Silha, M. Krsek, J.V. Skrha, P. Sucharda, B. Nyomba, and L.J. Murphy Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance Eur J Endocrinol 149 4 2003 331 335 10.1530/eje.0.1490331
31. J.H. Lee, J.L. Chan, N. Yiannakouris, M. Kontogianni, E. Estrada, R. Seip, and et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects J Clin Endocrinol Metab 88 10 2003 4848 4856 10.1210/jc.2003-030519
32. N. Iqbal, P. Seshadri, L. Stern, J. Loh, S. Kundu, T. Jafar, and et al. Serum resistin is not associated with obesity or insulin resistance in humans Eur Rev Med Pharmacol Sci 9 3 2005 161
33. G. Norata, M. Ongari, K. Garlaschelli, S. Raselli, L. Grigore, and A. Catapano Plasma resistin levels correlate with determinants of the metabolic syndrome Eur J Endocrinol 156 2 2007 279 284 10.1530/eje.1.02338
34. A.K. Singh, S. Tiwari, A. Gupta, S.M. Natu, B. Mittal, and A.B. Pant Association of resistin with metabolic syndrome in Indian subjects Metab Syndr Relat Disord 10 4 2012 286 291 10.1089/met.2011.0128
35. R. Kelishadi, M. Hajizadeh, G. Ardalan, P. Poursafa, and M. Fakhri Association of resistin and hs-CRP with liver enzymes and components of the metabolic syndrome in Iranian adolescents with excess weight: the CASPIAN-III Study Pak J Med Sci 29 1 Suppl. 2013
36. D.A. Luis, M. González Sagrado, R. Conde, R. Aller, and O. Izaola Resistin levels and inflammatory markers in patients with morbid obesity Nutr Hosp 25 4 2010 630 634
37. E. Makni, W. Moalla, L. Benezzeddine-Boussaidi, G. Lac, Z. Tabka, and M. Elloumi Correlation of resistin with inflammatory and cardiometabolic markers in obese adolescents with and without metabolic syndrome Obes Facts 6 4 2013 393 404
38. F. Koç, M. Tokaç, V. Kocabaş, C. Kaya, S. Büyükbaş, S. Erdem, and et al. Ghrelin, resistin and leptin levels in patients with metabolic syndrome Eur J Gen Med 8 2 2011 92 97
39. C.-C. Chen, T.-C. Li, C.-I. Li, C.-S. Liu, H.-J. Wang, and C.-C. Lin Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters Metabolism 54 4 2005 471 475 10.1016/j.metabol.2004.10.015
40. C. Shen, C.Y. Zhao, W. Wang, Y.D. Wang, H. Sun, W. Cao, and et al. The relationship between hepatic resistin over expression and inflammation in patients with nonalcoholic steatohepatitis BMC Gastroenterol 14 February 2014 39 10.1186/1471-230X-14-39
41. C.M. Kusminski, P.G. McTernan, and S. Kumar Role of resistin in obesity, insulin resistance and type II diabetes Clin Sci 109 3 2005 243 256